Exercises for at home | Exercises with existing heart muscle weakness

Exercises for at home For exercises that can be done from home, light endurance exercises and gymnastic exercises are particularly suitable. During the execution of the exercise, it is important to keep the pulse within the permitted range to avoid overexertion. 1) Running on the spot Start running slowly on the spot. Make sure that … Exercises for at home | Exercises with existing heart muscle weakness

Endurance training – what needs to be considered | Exercises with existing heart muscle weakness

Endurance training – what needs to be considered During endurance training it is important to carry out an individual analysis of the performance of each patient, as the heart must not be overloaded. A first classification is made based on the NYHA classification, but above all the individual maximum achievable oxygen uptake (VO2peak) plays a … Endurance training – what needs to be considered | Exercises with existing heart muscle weakness

Summary | Exercises with existing heart muscle weakness

Summary All in all, the exercises for cardiac insufficiency represent an important component of the therapy and are essential for increasing the patient’s resilience. Through regular training, many patients can increase their endurance and thus perform more everyday tasks again. As a result, the patients feel better overall and experience an increase in their quality … Summary | Exercises with existing heart muscle weakness

Physiotherapy for heart muscle weakness

Physiotherapy is an important component in the treatment of heart muscle weakness. Contrary to the general belief, it is beneficial to remain physically active despite the physical limitations and to train endurance and muscle strength. The goals set in physiotherapy and the individual therapy plan make it possible for patients with heart muscle weakness to … Physiotherapy for heart muscle weakness

Alirocumab: Effects, Uses & Risks

Alirocumab is an experimental drug for hypercholesterolemia. It is one of the monoclonal antibodies. Alirocumab was introduced in May 2013 at “Pharmacon Meran” by Austrian scientist Manfred Schubert-Zsilavecz. What is alirocumab? Alirocumab is an experimental drug for hypercholesterolemia. Alirocumab functions as an inhibitor (inhibitor) of the human enzyme proprotein convertase subtilisin/kexin type 9 – PCSK9 … Alirocumab: Effects, Uses & Risks